Research Study

M4OC-Prevent: Metformin for Oral Cancer Prevention
Principal Investigator 
Miriam Rosin

Overview

Body Locations and Systems 
Oral Cancer
ClinicalTrials.gov# 
NCT02581137
Status 
Recruiting
Study Start/End 
Jun 7, 2016 to Dec 14, 2018
Locations 
Vancouver General Hospital
Name/Title 
Leigha Rock, Research Coordinator
Phone 
604-675-8057
Purpose of Study 

This phase IIa trial studies how well metformin hydrochloride works in preventing oral cancer in patients with an oral premalignant lesion (oral leukoplakia or erythroplakia). Oral premalignant lesions look like red or whitish plaques or lesions in the mouth that do not rub off and can be associated with a higher risk of cancer. Metformin hydrochloride may help prevent oral cancer from forming in patients with an oral premalignant lesion.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.